Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NVD-001 for degenerative lumbar spondylolisthesis
NCT03100032Phase 2Completed
- Sponsor
- Novadip Biosciences
- Start
- Jan 2017
- Primary completion
- Jan 2021
- Modality
- Stem Cell Therapies
- Countries
- 3
01
Overview
A Phase 2 trial of NVD-001 in degenerative lumbar spondylolisthesis (DLS), sponsored by Novadip Biosciences. Started Jan 2017; status: completed.
02
Drugs
NVD-001
03
Conditions
degenerative lumbar spondylolisthesis (DLS)
Beyond the preview
Go deeper on NCT03100032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03100032.